EP Patent

EP2494962A2 — Pulmonary delivery for levodopa

Assigned to Civitas Therapeutics Inc · Expires 2012-09-05 · 14y expired

What this patent protects

Methods of producing spray dried particles are provided, which particles comprise L-Dopa and sodium chloride. The particles are used to treat parkinsons's disease and are suitable for delivery to the pulmonary system of a patient.

USPTO Abstract

Methods of producing spray dried particles are provided, which particles comprise L-Dopa and sodium chloride. The particles are used to treat parkinsons's disease and are suitable for delivery to the pulmonary system of a patient.

Drugs covered by this patent

Patent Metadata

Patent number
EP2494962A2
Jurisdiction
EP
Classification
—
Expires
2012-09-05
Drug substance claim
No
Drug product claim
No
Assignee
Civitas Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.